Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

ClinicalTrials.gov ID: NCT05582993

Public ClinicalTrials.gov record NCT05582993. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Prospective, Open-label, Uncontrolled, Multicenter Study on Efficacy and Safety of Prophylaxis With Vonicog Alfa (rVWF) in Children Diagnosed With Severe Von Willebrand Disease

Study identification

NCT ID
NCT05582993
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Takeda
Industry
Enrollment
24 participants

Conditions and interventions

Interventions

  • Vonicog Alfa Biological
  • ADVATE Biological

Biological

Eligibility (public fields only)

Age range
Up to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 5, 2024
Primary completion
Apr 10, 2030
Completion
Apr 10, 2030
Last update posted
May 26, 2026

2024 – 2030

United States locations

U.S. sites
11
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35223 Recruiting
Bleeding and Clotting Disorders Institute Peoria Illinois 61614 Recruiting
Riley Hospital for Children Indiana University Health Indianapolis Indiana 46202 Recruiting
University of Iowa Hospitals & Clinics PARENT Iowa City Iowa 52242 Recruiting
Childrens Hospital of Michigan Detroit Michigan 48201 Recruiting
Michigan State University Center for Bleeding Disorders & Clotting Disorders East Lansing Michigan 48824 Recruiting
Children's Health Care d/b/a Children's Minnesota Minneapolis Minnesota 55404 Recruiting
Cure 4 the Kids Las Vegas Nevada 89135 Recruiting
Rutgers - Robert Wood Johnson Medical School New Brunswick New Jersey 08901 Recruiting
New York - Presbyterian/Weill Cornell Medical Center New York New York 10021 Recruiting
Medical University of South Carolina (MUSC) Charleston South Carolina 29425 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05582993, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05582993 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →